Clinical Trial: Impact of Optical Genome Mapping in Acute Myeloblastic Leukemia
Study Status: Completed
Recruit Status: RECRUITING
Condition: Acute Myeloblastic Leukemia
Study Type: OBSERVATIONAL
Official Title: Contribution of Optical Genome Mapping to the Prognostic Classification of Acute Myeloblastic Leukemia Evaluation of the Clinical Utility of DNA Optical Mapping in the Management of Acute Myeloblastic
Brief Summary:
A retrospective study using a new technology will be performed: the Optical Genome Mapping (OGM) on acute myelogenous leukemia (AML) samples stored at the CRB-Cancer of the Bordeaux University Hospital and annotated in the DATAML clinical database.The main objective is to estimate the proportion of AML patients for whom OGM detects at least one additional abnormality compared to conventional techniques.This study will constitute an important step in the validation of COA as a reference technique for cytogenetic…
Read more